Cercare

I tuoi risultati

Visualizza 10 su 12 risultati

La salute è un diritto umano fondamentale e il conseguimento della parità di accesso ai medicinali è essenziale per garantire la salute pubblica. L'attuale sistema di innovazione farmaceutica dipende in larga misura dal settore privato e la remunerazione dell'innovazione si fonda principalmente sulle esclusive. Tale sistema comporta svariate sfide, come ad esempio il fatto che l'innovazione è guidata dalla dimensione del mercato, il parziale disallineamento fra le priorità di ricerca e sviluppo dell'industria ...

Antimicrobial-resistant infections are predicted to become the second biggest cause of death worldwide by 2050. Despite increasing investment in the development of new antimicrobials, awareness campaigns on antimicrobial misuse and abuse, and monitoring of antimicrobial use and resistance in animals, humans and the environment, antimicrobial resistance continues to grow and the last three decades have not seen even one novel antimicrobial class reach the market. Could the answer lie in a 'Trojan ...

Scientific evidence indicates that beneficial microorganisms (that live in nearly ubiquitous communities called microbiota) are an essential component of human health, and could be a new frontier for personalised medicine to fight non-communicable diseases and improve human health. For their potential benefits to reach society, the EU should consider standardisation, protocols, and a regulatory framework to support research and innovation.

Recent research suggests that the future combat against antimicrobial resistance (AMR) may involve probiotic-based approaches. Their use in our microbial ecosystems, including humans, animals and the healthcare environment, may provide a novel approach which deserves exploration.

Laboratory meat is grown from a small number of cells taken from a live animal and placed in a growth medium in a bioreactor where they proliferate independently. If meat cultured in this way became widely available, it could significantly alleviate the environmental problems currently caused by livestock production - such as greenhouse gas emissions and nitrogen pollution of waterways - without requiring humans to alter their consumption patterns. This publication provides an overview of the potential ...

This reports summarises four presentations by experts and discussion which took place at the workshop “Stronger Bacteria. Weaker Antimicrobial. 1000000 deaths in EU by 2050. "An Urgent Strong Antimicrobial Action Plan"”. Antimicrobial resistance (AMR) is a complex issue of global concern. With the aim of discussing the main challenges related to this topic and the recently published “A European One Health Action Plan against Antimicrobial Resistance (AMR)”, the workshop was hosted by Ms Soledad CABEZÓN ...

This study reviews existing scientific evidence regarding the impact of organic food on human health from an EU perspective, with a focus on public health. The development of environmentally sustainable and healthy food systems is an international priority. The study examines how organic food and organic agriculture can contribute to this in relation to public health. Human and animal studies directly addressing the health effects of organic food are reviewed. Furthermore, evidence linking principles ...

The rise of antimicrobial resistance – when bacteria and other microorganisms become resistant to the treatments used against the infections they cause – is a pressing public health issue. Cross-sector efforts, particularly awareness-raising, are being intensified, both in the EU and globally. This 'At a glance' note updates an earlier version of June 2015: PE 559.484.

This report summarises the presentations and discussions at the Workshop on ‘Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance’, held at the European Parliament in Brussels, on Tuesday 24 February 2015. The aim of the workshop was to discuss the main challenges and future perspectives related to the topic of patient safety and the threat of antimicrobial resistance in Europe. The workshop was hosted by MEP Piernicola PEDICINI, ENVI Committee Rapporteur for ...

The discovery of antibiotics revolutionised the treatment of infectious diseases. Their use and misuse, however, have contributed to what is known as 'antibiotic resistance'. Each year in the European Union (EU), over 25 000 people die from infections caused by antibiotic-resistant bacteria. This is not only a significant health concern, but also a food safety problem. Antibiotic resistance will remain an EU priority after 2016 and has been included on the G7 Summit agenda.